Table 1. Patient characteristics.
| Number | Mean | Range | |
|---|---|---|---|
| Control individuals (n = 15) | |||
| Age (years) | 63 | 50–76 | |
| Gender (M/F) | 5/10 | ||
| Monoclonal gammapathy of undetermined significance (n = 37) | |||
| Age (years) | 73 | 46–88 | |
| Gender (M/F) | 17/20 | ||
| Multiple myeloma (n = 17) | |||
| Age (years) | 72 | 52–86 | |
| Gender (M/F) | 11/6 | ||
| M-component type | |||
| IgG | 11 | ||
| IgA | 2 | ||
| Light chain type | |||
| kappa | 3 | ||
| lambda | 0 | ||
| NA | 1 | ||
| ISS Stage1 | |||
| Stage I | 6 | ||
| Stage II | 2 | ||
| Stage III | 6 | ||
| NA | 3 | ||
| Adverse cytogenetics | |||
| 13q | 5 | ||
| t(4,14) | 1 | ||
| 17p | 1 | ||
| Plasma cells in BM (%) | 38,8 | 3–78 | |
1ISS: International staging system, NA: not available